SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-007493
Filing Date
2024-03-12
Accepted
2024-03-12 17:13:01
Documents
8
Period of Report
2024-04-10

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A wint20240308_def14a.htm DEF 14A 191032
2 a01.jpg GRAPHIC 241455
3 a02.jpg GRAPHIC 239660
4 wint20240211_pre14aimg001.jpg GRAPHIC 6273
5 wint20240211_pre14aimg002.jpg GRAPHIC 1374
6 wint20240211_pre14aimg003.jpg GRAPHIC 2378
7 wint20240211_pre14aimg004.jpg GRAPHIC 1635
8 wint20240211_pre14aimg005.jpg GRAPHIC 975
  Complete submission text file 0001437749-24-007493.txt   873079
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39290 | Film No.: 24743313
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)